Lipid lowering therapy in type 2 diabetes

ISSN： 0043-5341

Source： Wiener Medizinische Wochenschrift, Vol.161, Iss.11-12, 2011-06, pp. : 289-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid management in Type 2 diabetes: the case for combination therapy?

By Saely Christoph H Drexel Veronika Vonbank Alexander Drexel Heinz

Therapy, Vol. 8, Iss. 2, 2011-03 ,pp. : 129-141

Future Medicine

Access to resources Recommend Favorite

Lipid‐lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic

INTERNAL MEDICINE JOURNAL, Vol. 48, Iss. 2, 2018-02 ,pp. : 201-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prescribing practices and clinical predictors of glucose‐lowering therapy within the first year in people with newly diagnosed Type 2 diabetes

DIABETIC MEDICINE, Vol. 32, Iss. 12, 2015-12 ,pp. : 1546-1554

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aggressive Antihypertensive Treatment and Serum Lipid Lowering Therapy Are Necessary to Prevent Deterioration of the Renal Function Even in Elderly Type 2 Diabetic Patients with Persistent Albuminuria

Gerontology, Vol. 48, Iss. 5, 2002-08 ,pp. : 302-308

Karger

Access to resources Recommend Favorite

Impact of rosiglitazone therapy on the lipid profile, glycemic control, and medication costs among type 2 diabetes patients

By Suh Dong-Churl Lee Dong-Hyun McGuire Michael Kim Chul-Min

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1623-1633

Informa Healthcare

Access to resources Recommend Favorite